Literature DB >> 21928720

Bovine corneal epithelial primary cultures as an in vitro model for ophthalmic drugs studies.

Grazyna Sygitowicz1, Danuta Zapolska-Downar, Magdalena Paluch, Tomasz Stawarski, Edmund Sieradzki, Dariusz Sitkiewicz.   

Abstract

In the recent years a significant development of investigations with regard to bioavailability of ocular drugs has been noticed. The corneal epithelial barrier is the main pathway for ocular penetration of topically applied ophthalmic drugs into the anterior chamber. To work out an in vitro model of bovine corneal epithelial primary cultures and exercise it for permeability research with lipophilic and hydrophilic markers, permeability coefficients estimation of the 6-carboxyfluorescein and rhodamin B was made. The corneal epithelial cultures of the 3th or 4th passage were chosen for layered culture with inserts based on the liquid-liquid interface (for the first week) and the air-liquid interface (for the two following weeks). On the 7th, 12th, 18th, 21st experiment day TER values, and on the 21st day drug permeability coefficients, were determined. The mean TER values of the 7th, 12th, 18th, 21st day of corneal epithelial culture were: 122.14, 155.14, 198.43 and; 247.43 Wcm2, respectively. The mean values of permeability coefficients on the 21st day of culture for 6-carboxyfluorescein and rhodamin B were 3.87 +/-0.10 x 10(-6)cm/s and 3.65 +/- 0.06 x 10(-6)cm/s, respectively. We state that the in vitro bovine corneal epithelial primary culture model is useful for ocular studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928720

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  2 in total

Review 1.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Long-term culture of feline oviduct epithelial cells on permeable filter supports.

Authors:  Susanne Eder; Karin Müller; Shuai Chen; Jennifer Schoen
Journal:  Cytotechnology       Date:  2022-09-05       Impact factor: 2.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.